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Abstract 
Objective: To elicit the structure of isolated compounds from roots of sidaguri (Sida rhombifolia 
Linn). Material and Methods: Several organic standard protocols were involved, including 
extraction, fractionation, and phytochemical testing. Further spectroscopy methods, FTIR and 
1HNMR, were used to determine the predicted structure of molecules, while their ability to 
inhibit cyclooxygenase (COX 1 and 2) were tested using in vitro method. Results: Overall 
assessments showed that the structure of the sidaguri is a long chain aliphatic carboxylic acid and 
identified as Z-3, 6, 6 trimethylhept-2-en-1-ol (T12) and nonanoic (T13). Both isolates 
significantly inhibit COX-1 and COX-2 non-selectively (the COX-1/COX-2 ratio for T12 was 
0.91 and 0.82; while COX-1/COX-2 ratio for T13 was 0.89 and 0.87 at concentrations of 0.05 
and 0.025 µg/mL respectively). Conclusion: The active compounds of Sidaguri have anti-
inflammatory effect by inhibiting COX non-selectively. 
 
Keywords: Sida Plant; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2.
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Introduction 
Sidaguri or Sida rhombifolia Linn from family of Malvaceae is found widely used as anti-
inflammatory agents for peoples in some area [1]. That extract of water-alcoholic of the leaf of 
sidaguri with a dosage of 400 mg/kg body-weight could inhibit edema in rats, which induced by 1% 
of carrageenan [2]. The longest duration for analgesic activities of root extract of sidaguri was 
found at concentration 2.4 g/kg/bw in 13.02 minutes [3]. 
Mostly all parts of sidaguri can be used for medical treatment such as treatment the stings 
and bites of scorpions, snakes, and wasps; skin diseases, and sores; fever, gum infections; and 
swelling. Studies of ethanol and water extract of the whole part of sidaguri demonstrated highly 
potent anti-inflammatory activities [4]. Besides anti-inflammatory potency, extract of sidaguri also 
exhibits other pharmacological and biological activities by inhibiting cyclooxygenase enzyme, 
especially prostaglandin biosynthesis and bacterial activity [5,6]. 
Recent study using Wistar rats as a model of periapical lesion, the efficacy of an ethanolic 
extract of the root bark of sidaguri and confirmed its potency as an anti-inflammatory agent. 
However no study has been carried out to evaluate the pharmacological potency of root bark extract 
of sidaguri in inhibiting cyclooxygenase enzyme [7,8]. 
In the previous studies, the presence of some ecdysteroid and their glycosides in sidaguri 
extract has been reported. They consist of four known compounds — ecdysone; 20-
hydroxyecdysone; 2-deoxy-20-hydroxyecdysone-3-O-beta-D-glucopyranoside; 20- hydroxyecdysone 
-3-O-beta-D-glucopyranoside which are reported for the first time. Sterols (β-sitosterol, 
stigmasterol, campesterol, stigmasterol, spinasterol, and cholesterol), n-alkanes (e.g., nonacosane and 
hentriacontane) and n-alcohols were also identified from the whole dried and aerial parts of S. 
rhombifolia. β-phenethylamine, ψ-ephedrine, quinazoline like vasicine, vasicinol, vasicinone, 
carboxylated tryptamines such as S-(+)-Nb-methyltryptophan methyl ester, choline, and betaine 
were isolated from aerial part [9]. However lack of studies examine the chemically active constituent 
of the root bark extract of sidaguri. 
Based on the above finding, the aim of this research is to isolate, identify, characterize and 
elucidate the active constituent of root bark extract of sidaguri in its polar and non-polar fraction, 
and to examine its inhibition activity to cyclooxygenase enzyme. 
 
Material and Methods 
Collection and Preparation of Plant Material 
Root-bark of sidaguri were taken from Bone Regency, South Sulawesi. The material was 
washed with clean water few times and openly air-dried at room temperature before cutting to small 
pieces and grinding to form soft particles, approximately 100 mesh in size, and kept in a dry place 
before using. 
 
Extraction, Fractionation, and Isolation 
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Approximately 1 kg of softly grinding dried samples of sidaguri root-bark was consecutively 
extracted under a reflux extraction using methanol at analytical grades to resulted in 4.33 g of 
viscous dark brownish color crude extract. This crude was then fractionated following Kupcha's 
fractionation and its modified methods [10]. 
The results were five major factions with a decreased of polarity from H2O, n-butanol, 
methanol, dichloromethane, and n-hexane. All resulted fractions were then tested for its inhibitory 
properties on cyclooxygenase enzyme. Prior to the inhibitory test, the fraction was taken for a series 
of phytochemical analysis in order to check the class of secondary metabolites that contained in the 
fraction as well as the crude extract. 
Identification and characterization of the active fractions were carried out using various 
chromatography analysis, including thin layer, flash, and vacuum column chromatography. Prior to 
the major chromatography works, a series of the single and double dimension of preparative thin 
layer chromatography was done to find suitable and appropriate eluent systems for the 
chromatography works.  
 
Predicted Structure of Molecules 
The results of pure compounds were then subjected to an instrumental analysis of UV, 
FTIR, and 1H-NMR spectroscopy to get the presumably correct structure of the active constituent 
sidaguri namely T12 and T13. The T12 and T13 further process was phytochemistry assessment 
using the protocol proposed by Harborne involving a test of alkaloids, steroids, flavonoids, saponins, 
and tannins [11]. 
 
COX-1 and COX-2 Inhibitory Activity 
The COX-1 and 2 assay were performed based on methods described by standard kit. 
Selectivity on COX-1 was calculated by Selectivity = 
Inhibition on COX-2
Inhibition on COX-1
 x 100%. 
 
Results 
Approximately 500 g of the soft grinding root bark of sidaguri were divided into 5 portions 
of 100 g. First portion of the materials was extracted under soxhlet with ethanol. This treatment was 
repeated for four remain portions. The results were then combined and evaporated under vacuum to 
provide brown viscous liquid crude extract about 4.33 g. 
Those fraction of n-hexane, approximately 0.77 g were subjected to liquid pressure column 
chromatography by impregnated the sample into a silica gel and flash gradually with solvent-based 
the solvent polarity from n-hexane 100% (few times as required) ; n-hexane-chloroform 8:2, 7:3, and 
5:5 chloroform-n-hexane 7:3; chloroform 100%; chloroform 100%; ethyl acetate-chloroform 2:8, 5:5; 
and 7:3, ethyl acetate; acetone, and methanol each 100% and overall resulted in 17 fractions. Two 
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fractions of T12 and T13 were then taken into further steps for purification by crystallization and 
recrystallization eluent of methanol-ethyl acetate for T12 and methanol-chloroform for T13 to 
resulted in 62.2 mg brownish color crystals and 4.2 g yellowish crystals of T12 and T13, 
respectively. Both compounds were then subjected to further one and two-dimensional thin layer 
chromatography using a series of eluents, which gave a bright spot under UV lamp (Table 1). 
 
Table 1. Organoleptic characterization of fractionation. 
Fraction Weight (g) Color Form 
n-hexane 0.77 Brown Paste 
Dichloromethane 0.49 Darkest brown Paste 
2-butanol 0.95 Brown Paste 
Chloroform 0.85 Light brown Paste 
H2O 1.27 Yellow Liquid 
 
Table 2 shows the chemical compound group of isolates. Terpennoid group were identified in 
both T12 and T13 and continued to structure elucidation using spectroscopy analysis including 
FTIR and 1H-NMR to determine the structure. The analysis of FTIR spectra of T12 and T13 were 
mentioned in (Table 3). 
 
Table 2. Phytochemistry assignment of T12 and T13. 
Secondary Metabolites Test 
Compounds 
T12 T13 
Alkaloids Meyer - - 
 Wagner - - 
Flavonoids  - - 
Saponin  - - 
Steroid  - - 
Terpenoid Lieberman-Baurchard ++ + 
+++: Strong Intensity Reaction; ++: Medium Intensity Reaction; +: Weak Intensity Reaction; -: No Detected. 
 
Table 3. FTIR spectrum of T12 and T13. 
T12 T13 
Wavelength abs (in cm-1) Functional Group Wavelength abs (in cm-1) Functional Group 
3446.79 -OH strains 3452.58 -OH strains 
2922.16 and 2852.72 -CH2-bending 2920.23; 2850.79; 1465.90 Aliphatic –CH 
1377.17 -CH3 bending 1377.17 -CH3 bending 
1465.04 and 1413.62 -CH2 and –CH3 1653.71 C=C aliphatic stretching 
1737.86 and 1710.86  1739.79; 1710.86 C=O strains 
1172.72 -C-O strains and stretch 1028.09 -C-O stretching and straining 
 
Further confirmation was done using 1H-NMR to give the assumptive structure of 
compounds T12 and T13. The 1H-NMR spectral data of both compounds were given in (Table 4 
and Figure 1). 
Two long-chain aliphatic carboxylic acids isolated from root bark of sidaguri were found 
(Table 4). T12 refers to Z-3, 6, 6 trimethylhept-2-en-1-ol, while T13 was nonanoic. 
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Table 4. 1H-NMR spectrum of T12 and T13 and the proposed structure of compounds (T12 and T13) 
isolated from roots of S. rhombifolia . 
T12 T13 
δH (in ppm) Multiplicity δH (in ppm) Multiplicity 
0.88 and 1.27 Multiplets 0.89 Singlet 
1.63 Singlet 1.32 and 1.62 Doublets and singlet 
5.36 Singlet 5.37 Singlet 
2.04 and 2.34 Doublet and singlet 3.32 Singlet 
4.17 Singlet 2.82 Doublet 
  2.29 Doublets of doublet 
Z-3,6,6 trimethylhept-2-en-1-ol Nonanoic 
  
 
 
 
Figure 1. NMR spectrum of (A) T12 and (B) T13. 
 
Both T12 and T13 showed higher inhibitory activity to COX-1 than COX-2 without 
depending on the concentration. T12 and T13 demonstrated no selectivity as COX-2 inhibitor 
(Table 5). 
 
Table 5. COX-1, COX-2 and the ratio inhibitor of two isolates by ELISA method. 
Isolate 
Concentration 
(µg/mL) 
Inhibition (%) 
Selectivity 
COX-1 COX-2 
T12 0.025 98.18 80.78 0.91 
 0.050 97.67 89.36 0.82 
T13 0.025 95.91 83.97 0.86 
 0.050 96.72 83.56 0.87 
 
Discussion 
The active compounds isolated from the root bark of sidaguri identified the presence of 
terpennoid groups, which is in accordance with the earlier reported studies although it was extracted 
from the whole part of sidaguri [5]. This means that different part of sidaguri contain the same 
terpennoid group. However further study should be carried out to examine the concentration of 
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terpennpoid group and other active groups. The isolated compounds refer to Z-3,6,6 trimethylhept-
2-en-1-ol and nonanoic. Nonanoic was also isolated from Piper nigrum at 60 µg/mL. The active 
compound of sidaguri extract from acetone fraction is n-hexacos-11-enoic acid. These differences 
may be due to different solvent used. These compounds was reported to show antibacterial activity 
against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella Typhimurium 
[6], while root bark of sidaguri only showed antibacterial activity against facultative anaerob Gram 
+ bacteria, Enteroc faecalis but no antibacterial activity against obligate anaerob bacteria; Actinomyces 
spp [3]. Another investigations on the leaves of S. rhombifolia found aliphatics group cyclopropenoid 
fatty acid, myrstic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid [12]. More studies 
should be carried out to examine other functional groups contained in the root bark of sidaguri and 
its biological activities against other bacteria. 
In this study, the active compounds isolated from the root bark of sidaguri (T12 and T13) 
showed anti-inflammatory effect by inhibiting cyclooxygenase enzymes. Unfortunately, the isolated 
compounds not only inhibit COX-2 but also inhibit COX-1. The human COX enzyme is known to 
exist in two forms; COX-1 and COX-2. COX-1 is constitutively expressed to maintain housekeeping 
functions such as cytoprotection in the stomach, regulation of blood flow in the kidneys, and the 
formation of thromboxane which involves in platelet aggregation. In contrast to COX-1, COX-2 is 
inducible and synthesized in inflammed tissues. COX-2 is important in the production of 
proinflammatory mediator, the prostaglandins (PGs) which are known to sensitize peripheral 
nociceptors and increase neuronal excitability by regulating the activity of certain ion channels [13]. 
This may partly explain the root bark extracts of sidaguri can reduce the inflammation on 
rat periapical lesion model [8]. Extracts isolated from Piper nigrum at 60 µg/mL was also reported 
to be able to inhibit COX. [14] A low COX-2/COX-1 ratio si preferred which indicates a 
preferential COX-2 inhibitor that has a valuable pharmacological effect. Selective COX-2 inhibitor 
has been shown to have no severe side effects that can cause acute injury on tissue, and no 
prostaglandin synthesis on gastric mucosal that can develop to chronic ulceration [15,16]. 
In summary, two isolates have been identified from root bark extract of sidaguri which 
showed anti-inflammatory effect with no selective inhibitory activity on COX enzymes. Elucidation 
of molecular docking of the binding mode of inhibitors to COX should be carried out. 
 
Conclusion 
The structure of T12 and T13 are similar to the formation of fatty acid Z (-3, 6, 6 
trimethylhept-2-en-1-ol and nonanoic, respectively, and are able to non-selectively inhibit COX 
enzymes. 
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